Search results for "Breast Cancer"


 
Results 121 - 130 of about 233 for "Breast Cancer".
Sort by: Relevance | Newest | Oldest

MKSAP Quiz: maintaining bone health

A 54-year-old woman comes to the office for advice regarding maintaining bone health. She has no history of fracture. The patient recently had a lumpectomy and radiation therapy to treat breast cancer, is currently taking tamoxifen, and will begin taking an aromatase inhibitor in 2 months. She underwent menopause at age 52 years and has persistent hot flushes. Her risk factors for osteoporosis include a slim body habitus and a mother who had a hip fracture at age 67 years. Following a physical exam, lab results and a dual-energy x-ray absorptiometry scan, what pharmacologic agents can be started in this patient?
https://immattersacp.org/weekly/archives/2015/03/10/3.htm
10 Mar 2015

New heart disease test, drugs for flu, weight management

This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015

Most elderly women with early-stage breast cancer still undergo radiation after surgery

Nearly two-thirds of women 70 years or older with early-stage breast cancer continue to receive radiation treatment, even though a large, randomized clinical trial from 2004 showed that it did not reduce recurrence or prolong survival, a study found.
https://immattersacp.org/weekly/archives/2014/12/09/5.htm
9 Dec 2014

Chest radiation in girls with Wilms tumor may increase breast cancer risk in adulthood

Girls who receive chest radiation for pulmonary metastases from Wilms tumor, a childhood kidney cancer, may be at higher risk for breast cancer later in life, a new study reports.
https://immattersacp.org/weekly/archives/2014/10/28/5.htm
28 Oct 2014

MKSAP Quiz: evaluation for a self-detected lump under the arm

A 69-year-old woman is evaluated for a lump under her arm found on self-examination. She is otherwise healthy and has no other symptoms. Medical and family histories are unremarkable, and she takes no medications. A needle aspirate of the right axillary mass reveals adenocarcinoma. Bilateral mammography and breast MRI are normal. CT scan of the chest, abdomen, and pelvis demonstrates the enlarged axillary lymph node and no other abnormalities. What is the most appropriate initial treatment?
https://immattersacp.org/weekly/archives/2014/09/16/3.htm
16 Sep 2014

New warning for testosterone, approval for inhaled insulin

This update covers a revised warning on testosterone products about the risk of venous thromboembolism, and approval of a fast-acting inhaled insulin to treat diabetes in adults.
https://immattersacp.org/archives/2014/09/fda.htm
1 Sep 2014

ASCO guideline update changes tamoxifen recommendations

The American Society of Clinical Oncology (ASCO) recently released an updated guideline that increased the recommended length of tamoxifen therapy in women with hormone receptor-positive breast cancer.
https://immattersacp.org/weekly/archives/2014/06/03/2.htm
3 Jun 2014

New drugs approved for type 2 diabetes and COPD

This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014

Many general internists uncomfortable caring for childhood cancer survivors, unfamiliar with relevant cancer surveillance guidelines

Internists reported that they were “somewhat uncomfortable” caring for childhood cancer survivors, were unfamiliar with available surveillance guidelines, and preferred to collaborate with cancer treatment centers and clinicians in a recent survey.
https://immattersacp.org/weekly/archives/2014/01/07/4.htm
7 Jan 2014

Anastrozole may be effective for primary prevention of breast cancer in high-risk, postmenopausal women

A new study partially funded by industry indicated that the aromatase inhibitor anastrozole may be effective for primary prevention of breast cancer in high-risk, postmenopausal women, although an accompanying commentary did not agree.
https://immattersacp.org/weekly/archives/2013/12/17/5.htm
17 Dec 2013

Result Page: Prev   8   9   10   11   12   13   14   15   16   17   Next